chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: MISSED THE SECOND DOSE; A spontaneous case report was received from a caregiver on 14-Jun-2019 for four consumers.  Based on the information obtained from the caregiver, four individual case safety reports PVX201906-000497 (PVX2019-1546; mother) and PVX201906-000498 (PVX2019-1547, eldest daughter) PVX201906-000499 (PVX2019-1548; son) and PVX201906-000500 (PVX2019-1549; youngest daughter) were created and cross-linked in the database.  This case describes a 47-year-old adult female consumer who "missed the second dose", while being on Vivotif for an unknown indication.  Case report: The consumer took the first dose of Vivotif on 11-Jun-2019 and missed her second dose which was due on 13-Jun-2019.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "missed the second dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "missed the second dose" was considered as not applicable. US-PaxVax Berna GmbH-PVX201906-000498: US-PaxVax Berna GmbH-PVX201906-000499: US-PaxVax Berna GmbH-PVX201906-000500:
Sex: M
Vaccine: TYP
Symptoms: Product storage error
Clinical narrative: TOOK TWO UNREFRIGERATED DOSES OF VIVOTIF; This spontaneous case (PVX2019-1570) report was received from a pharmacist on 17-Jun-2019. It describes a male child consumer who "took two unrefrigerated doses of Vivotif". He was receiving Vivotif for an unknown indication.  Case report: The consumer took two unrefrigerated doses of Vivotif on unknown dates.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took two unrefrigerated doses of Vivotif" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took two unrefrigerated doses of Vivotif" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration, Product storage error
Clinical narrative: TOOK SECOND DOSE ON DAY 4; TOOK UNREFRIGERATED VIVOTIF DOSE; A spontaneous case report was received from a caregiver on 17-Jun-2019 for four consumers.  Based on the information obtained from the caregiver, four individual case safety reports PVX201906-000505 (PVX2019-1565; 14-year-old male consumer), PVX201906-000506 (PVX2019-1566, 10-year-old female consumer), PVX201906-000507 (PVX2019-1567; 13-year-old female consumer), and PVX201906-000508 (PVX2019-1568; 16-year-old female consumer) were created and cross-linked in the database.  This case describes a 16-year-old adolescent female consumer who "took second dose on day 4" and "took unrefrigerated Vivotif dose". The consumer was receiving oral Vivotif (one capsule every other day) (lot number: 3003277) for typhoid prophylaxis.  Case report: The consumer took the first dose of Vivotif on 14-Jun-2019 and took the second unrefrigerated dose a day late that was on 17-Jun-2019.  Action taken with Vivotif was not applicable.  The clinical outcome of the events was unknown.  Company's Comment: The causality of the events "took second dose on day 4" and "took unrefrigerated Vivotif dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the events "took second dose on day 4" and "took unrefrigerated Vivotif dose" was considered as not applicable. US-PaxVax Berna GmbH-PVX201906-000505:
Sex: F
Vaccine: TYP
Symptoms: Product storage error
Clinical narrative: TOOK FOUR UNREFRIGERATED DOSES OF VIVOTIF; This spontaneous case (PVX2019-1573) report was received from a pharmacist on 17-Jun-2019. It describes a female consumer who "took four unrefrigerated doses of Vivotif". She was receiving oral Vivotif (one dose every other day) (lot number: 3003278 and expiry date: May 2020) for typhoid fever prophylaxis.  Case report: The consumer took all the four unrefrigerated doses of Vivotif. She took the last dose on 17-Jun-2019.  Action taken with Vivotif was not applicable.   The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "took four unrefrigerated doses of Vivotif" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took four unrefrigerated doses of Vivotif" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: TOOK TWO DOSES IN A ROW; This spontaneous case (PVX2019-1589) report was received from a consumer on 19-Jun-2019. It describes a 38-year-old female consumer who "took two doses in a row". The consumer was receiving Vivotif for an unknown indication.  Case report: The consumer took two doses in a row. The doses were taken on 18-Jun-2019 and 19-Jun-2019, respectively.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took two doses in a row" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took two doses in a row" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: TOOK A WEEK GAP BETWEEN THE SECOND AND THE THIRD DOSE; This spontaneous case report (PVX2019-1603) was received from a caregiver on 20-Jun-2019. It describes a female consumer who "took a week gap between the second and the third dose". She was receiving Vivotif capsule for an unknown indication.  Case report: The consumer did not take Vivotif doses according to the schedule. The doses were taken on 10-Jun-2019, 12-Jun-2019, and 19-Jun-2019, respectively.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took a week gap between the second and the third dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took a week gap between the second and the third dose" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Incomplete course of vaccination
Clinical narrative: TRAVELING TO AN ENDEMIC AREA BEFORE COMPLETING VIVOTIF; This spontaneous case report (PVX2019-1671) was received from a pharmacist on 26-Jun-2019. It describes a 27-year-old female consumer who "traveling to an endemic area before completing Vivotif" (Inappropriate schedule of vaccine administered). She was receiving oral Vivotif capsule (one dose every other day; lot number: 3003275 and expiry date: May 2020) for typhoid fever prophylaxis.  Case report: The consumer took the first dose of Vivotif yesterday (25-Jun-2019) and had a planned travel to an endemic area on Friday (28-Jun-2019).  Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "traveling to an endemic area before completing Vivotif" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "traveling to an endemic area before completing Vivotif" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: TOOK TWO CAPSULES OF VIVOTIF IN A ROW INSTEAD OF EVERY OTHER DAY; This spontaneous case report (PVX2019-1688) was received from a pharmacist on 28-Jun-2019. It describes a 53-year-old male consumer who "took two capsules of Vivotif in a row instead of every other day" (Inappropriate schedule of vaccine administered). He was receiving oral Vivotif capsule (one dose every other day) for typhoid fever prophylaxis.  Case report: The consumer took two doses of Vivotif in a row instead of every other day.  Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took two capsules of Vivotif in a row instead of every other day" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took two capsules of Vivotif in a row instead of every other day" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: MISSED HIS LAST DOSE AND TOOK IT IN THE MORNING; This spontaneous case report (PVX2019-1694) was received from a healthcare professional on 28-Jun-2019. It describes a male consumer who "missed his last dose and took it in the morning" (Inappropriate schedule of vaccine administered). She was receiving Vivotif for an unknown indication.  Case report: The consumer missed his last dose of Vivotif and took it the next morning. She did not know the dates on which Vivotif was taken.    Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "missed his last dose and took it in the morning" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "missed his last dose and took it in the morning" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Product administration error
Clinical narrative: ATE 15 MIN AFTER THE FOURTH DOSE; This spontaneous case report (PVX2019-1744) report was received from a nurse on 03-Jul-2019. It describes a 67-year-old elderly male consumer who "ate 15 min after the fourth dose" (PT: Product administration error), while being on Vivotif for an unknown indication.  Case report: The consumer took the first three doses of Vivotif correctly, but he ate 15 min after the fourth dose. The first dose was taken on 27-Jun-2019 and the last dose on 03-Jul-2019.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "ate 15 min after the fourth dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "ate 15 min after the fourth dose" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Product administration error
Clinical narrative: TOOK DOSE ABOUT 15 MINUTES AFTER SHE DRANK COFFEE AND CREAM; This spontaneous case report (PVX2019-1749) was received from a healthcare professional on 05-Jul-2019. It describes a 47-year-old female consumer who "took dose about 15 minutes after she drank coffee and cream" (PT: Product administration error), while being on Vivotif for typhoid prophylaxis.  Case report: The consumer took a dose of Vivotif about 15 minutes after she drank coffee and cream on 06-Jun-2019.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took dose about 15 minutes after she drank coffee and cream" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took dose about 15 minutes after she drank coffee and cream" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration, Product storage error
Clinical narrative: MISSED TO TAKE THIRD DOSE ACCORDING TO SCHEDULE; This spontaneous case report (PVX2019-1763) was received from a consumer on 08-Jul-2019. It describes a 24-year-old female consumer who "missed to take third dose according to schedule", while being on oral Vivotif (one dose every other day) for typhoid fever prophylaxis.  Case report: The consumer took the first two doses of Vivotif then left the remaining two doses in the car. Thus, she missed to take her third dose of Vivotif, which was due on 06-Jul-2019.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "missed to take third dose according to schedule" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "missed to take third dose according to schedule" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Expired product administered
Clinical narrative: TOOK 4 DOSES OF EXPIRED VIVOTIF; This spontaneous case report (PVX2019-1843) was received from a consumer on 16-Jul-2019. It describes a female consumer who "took 4 doses of expired Vivotif" (PT: Expired product administered), while being on oral Vivotif (one dose every other day) (expiry date: Apr 2019) for typhoid fever prophylaxis.  Case report: The consumer took 4 doses of expired Vivotif. The last dose was taken on 14-Jul-2019.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took 4 doses of expired Vivotif" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took 4 doses of expired Vivotif" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Incomplete course of vaccination
Clinical narrative: DID NOT COMPLETE IMMUNIZATION ONE WEEK PRIOR TO TRAVEL TO AN ENDEMIC AREA; This spontaneous case report (PVX2019-1853) was received from a pharmacist on 17-Jul-2019. It describes an adult female consumer who "did not complete immunization one week prior to travel to an endemic area" (PT: Inappropriate schedule of product administration), while being on oral Vivotif capsule (one dose every other day) for typhoid prophylaxis.  Case report: The consumer took the first dose of Vivotif on 16-Jul-2019. On 21-Jul-2019, she had a planned travel to endemic area and her last dose would be on 22-Jul-2019.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "missed the second dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "missed the second dose" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration, Labelled drug-drug interaction medication error
Clinical narrative: TOOK MACROBID AND VIVOTIF TOGETHER; This spontaneous case report (PVX2019-1867) was received from a consumer on 18-Jul-2019. It describes a 60-year-old female consumer who "took Macrobid and Vivotif together" (PT: Labelled drug-drug interaction medication error), while being on Vivotif for an unknown indication and Macrobid (nitrofurantoin) for urinary tract infection (UTI).  Case report: The consumer was on a four-day therapy of Macrobid for UTI. On 17-Jul-2019, she took the first dose of Vivotif.  Action taken with Vivotif and Macrobid was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "missed the second dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "missed the second dose" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Incomplete course of vaccination
Clinical narrative: MISSED THE LAST DOSE; This spontaneous case report (PVX2019-1885) was received from a pharmacist on 22-Jul-2019. It describes a male consumer who "missed the last dose" (PT: Product dose omission), while being on therapy of Vivotif for an unknown indication.  Case report: The consumer took Vivotif doses on 14-Jul-2019, 16-Jul-2019, and 18-Jul-2019, respectively. He did not take the last dose.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "missed the last dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "missed the last dose" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Product administration error
Clinical narrative: TOOK THIRD DOSE OF VIVOTIF WITH FOOD; This spontaneous case report (PVX2019-1887) was received from a nurse on 22-Jul-2019. It described an adult female consumer who "took third dose of Vivotif with food" (PT: Product administration error), while being on Vivotif for an unknown indication.  Case report: The consumer took the third dose of Viovtif with food might be on 21-Jul-019.   Action taken with Vivotif was not applicable.  The clinical outcome was unknown.  Company's Comment: The causality of the event "took third dose of Vivotif with food" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took third dose of Vivotif with food" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration, Product storage error
Clinical narrative: DID NOT START VIVOTIF TWO WEEKS PRIOR TO TRAVELING TO AN ENDEMIC AREA; TOOK ONE UNREFRIGERATED DOSE OF VIVOTIF; This spontaneous case report (PVX2019-1893) was received from a pharmacist on 22-Jul-2019. It described a 19-year-old female consumer who "took one unrefrigerated dose of Vivotif" (PT: Product storage error) and "did not start Vivotif two weeks prior to traveling to an endemic area" (PT: Inappropriate schedule of product administration). The consumer was receiving oral Vivotif (one dose every other day) for typhoid fever prophylaxis.  Case report: The consumer took the first unrefrigerated dose of Vivotif on 20-Jul-2019. She had a planned trip to an endemic area on 29-Jul-2019.  Action taken with Vivotif was not applicable.  The clinical outcome of the reported events was unknown.  Company's Comment: The causality of the event "took one unrefrigerated dose of Vivotif" and "did not start Vivotif two weeks prior to traveling to an endemic area" was considered as not applicable. ; Sender's Comments: Company's Comment: The causality of the event "took one unrefrigerated dose of Vivotif"  and also "did not start Vivotif two weeks prior to traveling to an endemic area" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: MISSED TO TAKE THE DOSE ON DUE DATE; This spontaneous case report (PVX2019-1927) was received from a pharmacist on 25-Jul-2019. It described a female consumer who "missed to take the dose on due date" (PT: Product dose omission), while being on Vivotif for an unknown indication.  Case report: The consumer took a dose of Vivotif on 22-Jul-2019 and missed to take the scheduled dose on 24-Jul-2019.  Action taken with Vivotif was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "missed to take the dose on due date" was considered as not applicable. ; Sender's Comments: Company's Comment: The causality of the event "missed to take the dose on due date" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: TOOK VIVOTIF ON CONSECUTIVE DAYS; This spontaneous case report (PVX2019-1937) was received from a pharmacist on 26-Jul-2019. It described a female consumer who "took Vivotif on consecutive days" (PT: Inappropriate schedule of product administration), while being on oral Vivotif for typhoid fever prophylaxis.  Case report: The consumer took a dose of Vivotif on 25-Jul-2019 and 26-Jul-2019, respectively. Further, the consumer took Vivotif on 28-Jul-2019 and 30-Jul-2019.  Action taken with Vivotif was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "took Vivotif on consecutive days" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took Vivotif on consecutive days" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: TOOK THIRD DOSE TOO EARLY; This spontaneous case report (PVX2019-2086) was received from a physician on 12-Aug-2019. It described a female consumer who "took third dose too early" (PT: Inappropriate schedule of product administration), while being on Vivotif for an unknown indication.  Case report: The consumer took the third dose of Vivotif too early.  Action taken with Vivotif was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "took third dose too early" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took third dose too early" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Labelled drug-drug interaction medication error
Clinical narrative: TOOK ANTIBIOTIC WHILE ON VIVOTIF; This spontaneous case report (PVX2019-2096) was received from a consumer on 14-Aug-2019. It described a 68-years-old male consumer who "took antibiotic while on Vivotif" (PT: Labelled drug-drug interaction medication error), while being on Vivotif for an unknown indication. The consumer was taking an unspecified antibiotic for urinary tract infection (UTI).  Case Report: The consumer took Vivotif doses on 08-Aug-2019, 10-Aug-2019, 12-Aug-2019, and 14-Aug-2019, respectively. On 13-Aug-2019, he started taking an antibiotic for UTI, which was started long before Vivotif.  Action taken with Vivotif and the antibiotic was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took antibiotic while on Vivotif" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took antibiotic while on Vivotif" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Product storage error
Clinical narrative: TOOK TWO UNREFRIGERATED DOSES OF VIVOTIF; This spontaneous case report (PVX2019-2109) was received from a consumer on 14-Aug-2019. It described a male consumer who "took two unrefrigerated doses of Vivotif" (PT: Product storage error), while being on Vivotif for an unknown indication.  Case report: The consumer placed Vivotif doses at 78 to 80-degree Fahrenheit for 24 hours. Then, he placed it in the refrigerator for 1 hour before taking the first dose. The two doses were taken on Saturday and Monday. He also stated that he will go to another country on 24-Aug-2019.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took two unrefrigerated doses of Vivotif" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took two unrefrigerated doses of Vivotif" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Product storage error
Clinical narrative: TOOK THREE UNREFRIGERATED DOSES OF VIVOTIF; This spontaneous case report (PVX2019-2116) was received from a consumer on 15-Aug-2019. It described a female consumer who "took three unrefrigerated doses of Vivotif" (PT: Product storage error), while being on oral Vivotif (one dose every other day) for travelling to endemic area.  Case report: The consumer took three doses of Vivotif, which were no longer good to use. The doses were taken on Sunday, Tuesday, and Thursday. She would be leaving to the endemic area in a week.  Action taken with Vivotif was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "took three unrefrigerated doses of Vivotif" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took three unrefrigerated doses of Vivotif" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Incomplete course of vaccination
Clinical narrative: TOOK THREE DOSES BEFORE THE FOURTH DOSE WENT DOWN THE SINK; This spontaneous case report (PVX2019-2136) was received from a pharmacist on 20-Aug-2019. It described a female consumer who "took three doses before the fourth dose went down the sink" (PT: Product dose omission), while being on Vivotif for an unknown indication.  Case report: The consumer took the first three doses of Vivotif before the fourth dose went down the sink. She took the third dose on 11-Aug-2019.  Action taken with Vivotif was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "took three doses before the fourth dose went down the sink" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took three doses before the fourth dose went down the sink" was considered as not applicable
Sex: F
Vaccine: TYP
Symptoms: Product administration error
Clinical narrative: TOOK THE FIRST DOSE WITH A MEAL; This spontaneous case report (PVX2019-2153, PVX2019-2154) was received from a pharmacist on 22-Aug-2019. It described a 60-year-old female consumer who "took the first dose with a meal" (PT: Product administration error), while being on oral Vivotif (one dose every other day) for typhoid fever prophylaxis.  Case report: The consumer took the first dose of Vivotif with a meal on 22-Aug-2019. It was reported that she was planning on getting new doses to complete the course of Vivotif.  Action taken with Vivotif was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "took the first dose with a meal" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took the first dose with a meal" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: DID NOT TAKE VIVOTIF DOSES ACCORDING TO SCHEDULE; This spontaneous case report (PVX2019-2227) was received from a caregiver (consumer's wife) on 30-Aug-2019. It described a male consumer who "did not take Vivotif doses according to schedule" (PT: Inappropriate schedule of product administration), while being on oral Vivotif for typhoid fever prophylaxis.  Case report: The consumer took Vivotif doses on day 1, 4, 6, and 8. The consumer took Vivotif 3 weeks ago from the date of report.  Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "did not take Vivotif doses according to schedule" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "did not take Vivotif doses according to schedule" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Product storage error
Clinical narrative: TOOK VIVOTIF THAT WAS STORED IN A REFRIGERATOR WITH FLUCTUATING TEMPERATURES; This spontaneous case (PVX2019-2274) was received form a pharmacist on 05-Sep-2019. It described an adult male consumer who "took Vivotif that was stored in a refrigerator with fluctuating temperatures" (PT: Product storage error), while being on oral Vivotif capsule (1 capsule by mouth every other day) for typhoid prophylaxis.  Case report: The consumer took Vivotif doses, which were stored in a refrigerator with fluctuating temperatures. She did not know the total duration of each excursion but informed that the maximum temperature reached was 55-degree Fahrenheit and the lowest was 35 degree Fahrenheit. Lot number remained unknown.  Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "took Vivotif that was stored in a refrigerator with fluctuating temperatures" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took Vivotif that was stored in a refrigerator with fluctuating temperatures" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: TOOK ALL DOSES IN A ROW; This spontaneous case report (PVX2019-2336) was received from a consumer on 11-Sep-2019. It described a 60-year-old adult male consumer who "took all doses in a row" (PT: Inappropriate schedule of product administration), while being on oral Vivotif for typhoid prophylaxis   Case report: The consumer took all the doses of Vivotif every day from 07-Sep-2019 to 10-Sep-2019.  Action taken with Vivotif was not applicable.   The clinical outcome for the reported event was unknown.  Company's Comment: The causality of the event "took all doses in a row" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took all doses in a row" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: TOOK SECOND DOSE ON DAY 6; This spontaneous case report (PVX2019-2381) was received from a pharmacist on 17-Sep-2019. It described a male consumer who "took second dose on day 6" (PT: Inappropriate schedule of product administration), while being on Vivotif for an unknown indication.  Case report: The consumer took the second dose of Vivotif on day 6. The first two doses were taken on 11-Sep-2019 and 16-Sep-2019, respectively.  Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "took second dose on day 6" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took second dose on day 6" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: TOOK TWO DOSES CONSECUTIVELY; This spontaneous case report (PVX2019-2399) was received from a pharmacist on 19-Sep-2019. It described a female consumer who "took two doses consecutively" (PT: Inappropriate schedule of product administration), while being on Vivotif for an unknown indication.  Case report: The consumer took first two doses of Vivotif in a row. The doses were taken on 17-Sep-2019 and 18-Sep-2019, respectively.  Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "took two doses consecutively" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took two doses consecutively" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: TOOK DOSES EVERYDAY INSTEAD OF EVERY OTHER DAY; This spontaneous case report (PVX2019-2461) received from a pharmacist on 30-Sep-2019. It described a female consumer who "took doses everyday instead of every other day" (PT: Inappropriate schedule of product administration), while being on Vivotif for an unknown indication.  Case report: The consumer took doses of Vivotif every day instead of every other day.   Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "took doses everyday instead of every other day" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took doses everyday instead of every other day" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Product storage error
Clinical narrative: TOOK TWO UNREFRIGERATED DOSES; This spontaneous case report (PVX2019-2488) was received from a consumer on 03-Oct-2019. It described a female consumer who "took two unrefrigerated doses" (PT: Product storage error), while being on Vivotif for traveling.  Case report: The consumer got the Vivotif package (lot number: 3003285) from the pharmacy. However, she did not refrigerate it for a week and took first and second dose on 30-Sep-2019 and 02-Oct-2019 respectively.  Action taken with Vivotif with respect to reported event was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "took two unrefrigerated doses" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took two unrefrigerated doses" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Product storage error
Clinical narrative: TOOK UNREFRIGERATED LAST DOSE; This spontaneous case report (PVX2019-2493) was received from a consumer on 04-Oct-2019. It described a 26-year-old female consumer who "took unrefrigerated last dose" (PT: Product storage error), while being on oral Vivotif for typhoid prophylaxis.  Case report: The consumer started Vivotif (one capsule every other day, Oral) on 25-Sep-2019. She took her second and third dose on 27-Sep-2019 and 29-Sep-2019 respectively. She accidentally left the last dose unrefrigerated for 2 days at 68-degree Fahrenheit to 70 degree Fahrenheit. She took her last dose on 01-Oct-2019.   Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took unrefrigerated last dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took unrefrigerated last dose" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: TOOK SECOND DOSE 1 WEEK AFTER THE FIRST DOSE; This spontaneous case report (PVX2019-2503) received from a caregiver on 07-Oct-2019. It described a male consumer who "took second dose 1 week later after the first dose" (PT: Inappropriate schedule of product administration), while being on oral Vivotif for typhoid prophylaxis.  Case report: The consumer started oral Vivotif on 30-Sep-2019 and went out of the town without taking his Vivotif. He took the second dose on 07-Oct-2019.  Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "took second dose 1 week later after the first dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took second dose 1 week later after the first dose" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: TOOK VIVOTIF EVERY DAY INSTEAD OF EVERY OTHER DAY; This spontaneous case report (PVX2019-2517) was received from a pharmacist on 08-Oct-2019. It described a 49-year-old adult female consumer who "took Vivotif every day instead of every other day" (PT: Inappropriate schedule of product administration). The consumer was receiving oral Vivotif capsule for typhoid prophylaxis.  Case report: The consumer took all the doses of Vivotif every day instead of every other day. The doses were taken from 04-Oct-2019 to 07-Oct-2019.  Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "took Vivotif every day instead of every other day" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took Vivotif every day instead of every other day" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: MISSED TO TAKE THIRD DOSE ON TIME; This spontaneous case report (PVX2019-2527) was received from a consumer on 09-Oct-2019. It described a male consumer who "missed to take third dose on time" (PT: Product dose omission), while being on oral Vivotif for typhoid fever prophylaxis.  Case report: The consumer took the first and the second dose of Vivotif on 04-Oct-2019 and 06-Oct-2019 respectively. Then, he missed to take third dose, which was due on 08-Oct-2019.  Action taken with Vivotif with respect to reported event was not applicable.  The clinical outcome of the reported event was unknown  Company's Comment: The causality of the event "missed to take third dose on time" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "missed to take third dose on time" was considered as not applicable.
Sex: U
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: TOOK LAST DOSE A WEEK AFTER THE THIRD DOSE; This spontaneous case report (PVX2019-2530) was received from a pharmacist on 09-Oct-2019. It described a consumer who "took last dose a week after the third dose" (PT: Inappropriate schedule of product administration), while being on oral Vivotif for typhoid fever prophylaxis.  Case report: The consumer took all the three doses of Vivotif according to the schedule. However, the consumer took the fourth dose a week after the third dose.  Action taken with Vivotif with respect to the reported event was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "took last dose a week after the third dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took last dose a week after the third dose" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: TOOK TWO DOSES IN A ROW; This spontaneous case report (PVX2019-2572) was received from a consumer on 17-Oct-2019. It described a 17-year-old male consumer who "took two doses in a row" (PT: Inappropriate schedule of product administration), while being on oral Vivotif for an unknown indication.  Case report: The consumer did not take Vivotif according to schedule. He had taken his third and fourth dose on 16-Oct-2019 and 17-Oct-2019, respectively.  Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "took two doses in a row" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took two doses in a row" was considered as not applicable.
Sex: U
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: DID NOT TAKE DOSES ON TIME; A spontaneous case report was received from a nurse on 17-Oct-2019 for four consumers.  Based on the information obtained from the nurse four individual case safety report PVX201910-000804 (PVX2019-2599; first consumer), PVX201910-000805 (PVX2019-2600; second consumer), PVX201910-000806 (PVX2019-2601; third consumer), and PVX201910-000807 (PVX2019-2602; fourth consumer) were created and cross-linked in the database.  This case (PVX2019-2599) described a consumer who "did not take doses on time" (PT: Product dose omission), while being on oral Vivotif for typhoid fever prophylaxis.  Case report: The consumer took the first dose of Vivotif, then did not take the remaining doses for several days.  Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "did not take doses on time" was considered as not applicable. ; Sender's Comments: Company's Comment: The causality of the event "did not take doses on time" was considered as not applicable. US-PaxVax Berna GmbH-PVX201910-000805: US-PaxVax Berna GmbH-PVX201910-000806: US-PaxVax Berna GmbH-PVX201910-000807:
Sex: U
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: DID NOT TAKE DOSES ON TIME; A spontaneous case report was received from a nurse on 17-Oct-2019 for four consumers.  Based on the information obtained from the nurse four individual case safety report PVX201910-000804 (PVX2019-2599; first consumer), PVX201910-000805 (PVX2019-2600; second consumer), PVX201910-000806 (PVX2019-2601; third consumer), and PVX201910-000807 (PVX2019-2602; fourth consumer) were created and cross-linked in the database.  This case (PVX2019-2600) described a consumer who "did not take doses on time" (PT: Product dose omission), while being on oral Vivotif for typhoid fever prophylaxis.  Case report: The consumer took the first dose of Vivotif and then did not take the remaining doses for several days.  Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "did not take doses on time" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "did not take doses on time" was considered as not applicable. US-PaxVax Berna GmbH-PVX201910-000804:
Sex: U
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: DID NOT TOOK DOSES ON TIME; A spontaneous case report was received from a nurse on 17-Oct-2019 for four consumers.  Based on the information obtained from the nurse four individual case safety report PVX201910-000804 (PVX2019-2599; first consumer), PVX201910-000805 (PVX2019-2600; second consumer), PVX201910-000806 (PVX2019-2601; third consumer), and PVX201910-000807 (PVX2019-2602; fourth consumer) were created and cross-linked in the database.  This case (PVX2019-2601) described a consumer who "did not take doses on time" (PT: Product dose omission), while being on oral Vivotif for typhoid fever prophylaxis.  Case report: The consumer took the first dose of Vivotif, and then did not take the remaining doses for several days.  Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "did not take doses on time" was considered as not applicable.  ; Sender's Comments: Company's Comment: The causality of the event "did not take doses on time" was considered as not applicable. US-PaxVax Berna GmbH-PVX201910-000804:
Sex: U
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: DID NOT TAKE DOSES ON TIME; A spontaneous case report was received from a nurse on 17-Oct-2019 for four consumers.  Based on the information obtained from the nurse four individual case safety report PVX201910-000804 (PVX2019-2599; first consumer), PVX201910-000805 (PVX2019-2600; second consumer), PVX201910-000806 (PVX2019-2601; third consumer), and PVX201910-000807 (PVX2019-2602; fourth consumer) were created and cross-linked in the database.  This case (PVX2019-2602) described a consumer who "did not take doses on time" (PT: Product dose omission), while being on oral Vivotif for typhoid fever prophylaxis.  Case report: The consumer took the first dose of Vivotif, then did not take the remaining doses for several days.  Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "did not take doses on time" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "did not take doses on time" was considered as not applicable. US-PaxVax Berna GmbH-PVX201910-000804:
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: TOOK DOSES IN AN INAPPROPRIATE SCHEDULE; This spontaneous case report (PVX2019-2617) was received from a pharmacist on 21-Oct-2019. It described a 31-year-old female consumer who "took doses in an inappropriate schedule" (PT: Inappropriate schedule of product administration), while being on Vivotif for an unknown indication.  Case report: The consumer started Vivotif on 14-Oct-2019 and took her second dose on 16-Oct-2019 according to schedule but forgot to take her third dose on 18-Oct-2019. She took her third dose on 20-Oct-2019.  Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "took doses in an inappropriate schedule" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took doses in an inappropriate schedule" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Product administration error
Clinical narrative: TOOK ONE DOSE RIGHT AFTER A LARGE MEAL; This spontaneous case report (PVX2019-2614) was received from a consumer on 19-Oct-2019. It described a male consumer who "took one dose right after a large meal" (PT: Product administration error), while being on oral Vivotif (one dose every other day) for typhoid fever prophylaxis.  Case report: The consumer took his first dose of Vivotif on 18-Oct-2019 right after a large meal and not on an empty stomach. He took his second dose on 20-Oct-2019 on an empty stomach.   Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "took one dose right after a large meal" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took one dose right after a large meal" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Product administration error
Clinical narrative: TOOK VIVOTIF WITH A MULTIVITAMIN; This spontaneous case report (PVX2019-2624) was received from a nurse on 21-Oct-2019. It described a female consumer who "took Vivotif with a multivitamin" (PT: Product administration error). The consumer was receiving Vivotif for typhoid prophylaxis.  Case report: The consumer took Vivotif with a multivitamin.  Action taken with Vivotif with respect to reported event was not applicable.  The clinical outcome of reported event was unknown.  Company's Comment: The causality of the event "took Vivotif with a multivitamin" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took Vivotif with a multivitamin" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: DID NOT TAKE THIRD DOSE ON TIME; This spontaneous case report (PVX2019-2634) was received from a pharmacist on 22-Oct-2019. It described a male consumer who "did not take third dose on time" (PT: Product dose omission), while being on oral Vivotif for typhoid fever prophylaxis.  Case report: The consumer missed to take third dose of Vivotif, which was due on 21-Oct-2019.  Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "did not take third dose on time" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "did not take third dose on time" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Product administration error
Clinical narrative: TOOK FIRST DOSE ON A FULL STOMACH; This spontaneous case report (PVX2019-2636) was received from a consumer on 21-Oct-2019. It described a male consumer who "took first dose on a full stomach" (PT: Product administration error), while being on Vivotif for an unknown indication.  Case report: The consumer took the first dose of Vivotif on a full stomach.  Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "took first dose on a full stomach" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took first dose on a full stomach" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: MISSED SECOND DOSE; This spontaneous case report (PVX2019-2642) was received from a healthcare professional on 22-Oct-2019. It described a female consumer who "missed second dose" (PT: Product dose omission), while being on Vivotif for an unknown indication.  Case report: The consumer started Vivotif on 18-Oct-2019. She missed her second dose, which was due on 20-Oct-2019.   Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "missed second dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "missed second dose" was considered as not applicable.